
Identität
Crlx101
Nicht angegeben · C20H16N2O4
01Identität
| Lazychem ID | LC-51694 |
|---|---|
| CAS RN | Nicht angegeben |
| PubChem CID | 184196 |
| Molecular formula | C20H16N2O4 |
| Molecular weight | 348.4 g/mol |
| IUPAC name | (19R)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione |
| InChIKey | VSJKWCGYPAHWDS-HXUWFJFHSA-N |
02Struktur und Stereochemie

The parsed structure contains 5 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre. These statements are calculated from the published structure string.
| Defined stereocentres | 1 |
|---|---|
| Ring count | 5 |
| Secondary amines | 0 |
| Tertiary amines | 0 |
| SMILES | CC[C@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O |
|---|---|
| InChI | Nicht angegeben |
03Stereochemistry
The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.
Published same-connectivity configurations
2 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.


Irinotecan EP Impurity D / Topotecan Related Compound C / Camptothecin
CAS 7689-03-4
VSJKWCGYPAHWDS-FQEVSTJZSA-N
1 defined, 0 unassigned centres
Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
04Status in Indien
Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.
05Namen und Beziehungen
API und Ausgangsarzneistoff
Nicht angegeben
Namen und Beziehungen
06Quellen
- S01PubChem CID 184196
Structure and machine-readable chemical identifiers.
